logo
welcome
Reuters

Reuters

Novartis must face claims it paid kickbacks to promote MS drug, US appeals court rules

Reuters
Summary
Nutrition label

77% Informative

A U.S. appeals court on Friday revived a whistleblower lawsuit accusing Novartis of paying kickbacks to doctors to promote its drug Gilenya .

The whistleblower Steven Camburn said the drugmaker paid doctors thousands of dollars and treated them to dinners at high-end restaurants.

He said this caused government health insurance programs including Medicare Part D, Medicaid and TRICARE to be defrauded.

VR Score

87

Informative language

94

Neutral language

38

Article tone

formal

Language

English

Language complexity

58

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links